市場調査レポート
商品コード
1327586
経カテーテル僧帽弁修復術市場(金額、数量、ASP):セグメント別規模、シェア、動向およびSWOT分析、法規制および償還動向、手技、2033年までの予測Transcatheter Mitral Valve Repair Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経カテーテル僧帽弁修復術市場(金額、数量、ASP):セグメント別規模、シェア、動向およびSWOT分析、法規制および償還動向、手技、2033年までの予測 |
出版日: 2023年06月27日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
経カテーテル僧帽弁修復術は現在、非外科的な高リスクの変性僧帽弁閉鎖不全症に対してFDAの承認を受けています。僧帽弁形成術は、短期的にも長期的にも死亡率や罹患率が低いため、適応のある患者には僧帽弁置換術よりも好ましい治療法です。重症の僧帽弁閉鎖不全症患者の約50%は年齢や他の疾患のために手術の適応がないです。経カテーテル僧帽弁形成術(TMVR)は、僧帽弁閉鎖不全症(MR)の低侵襲治療に使用されます。
当レポートは、世界の経カテーテル僧帽弁修復術市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Transcatheter Mitral Valve Repair Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Repair market for the year 2020 and beyond. Transcatheter Mitral Valve Repair is currently FDA approved for non-surgical high risk degenerative mitral regurgitation. Mitral valve repair treatment is preferred over mitral valve replacement in patients who are eligible because it is linked with a lower short term and long term mortality and morbidity rates. Approximately, 50% of the severe mitral regurgitation patients are not eligible for surgery due to their age or other disorders. Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR).
Each of the covered 25 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Japan, Australia, Canada, Mexico, Denmark, Ireland, Netherlands, New Zealand, Sweden, Switzerland, Austria, Belgium, Finland, Norway, Poland, and Portugal.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -